ConductScience.org, home

Paper29933129

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3.

Greenall SA and 3 others. Transl Oncol, 2018. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3. Papers, record 29933129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29933129

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3.
PubMed
Journal
Transl Oncol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2021-01-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greenall SASameer A
2Donoghue JJacqueline
3Johns TGTerrance G
4Adams TETimothy E

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110961344Structure and function of the type 1 insulin-like growth factor receptor.Cell Mol Life Sci2000https://conductscience.org/library/papers/10961344PubMed
29408744Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.Endocr Rev1997https://conductscience.org/library/papers/9408744PubMed
320515953A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo.Mol Cancer Ther2010https://conductscience.org/library/papers/20515953PubMed
412531883A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.J Clin Invest2003https://conductscience.org/library/papers/12531883PubMed
52546147Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2546147PubMed
618089823PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib.Cancer Res2007https://conductscience.org/library/papers/18089823PubMed
710207053Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.Mol Cell Biol1999https://conductscience.org/library/papers/10207053PubMed
82837209Evidence of autocrine regulation in human hepatoma cell lines.Biochem Biophys Res Commun1988https://conductscience.org/library/papers/2837209PubMed
99707622Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9707622PubMed
1015019164Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.Cancer Lett2004https://conductscience.org/library/papers/15019164PubMed
1126429980Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.Clin Cancer Res2015https://conductscience.org/library/papers/26429980PubMed
1224747966Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo.Oncogene2015https://conductscience.org/library/papers/24747966PubMed
1319762238Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).Bioorg Med Chem Lett2009https://conductscience.org/library/papers/19762238PubMed
1415964556Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.Biochem Biophys Res Commun2005https://conductscience.org/library/papers/15964556PubMed
1519706799
Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Clin Cancer Res2009https://conductscience.org/library/papers/19706799PubMed
1618350600Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.World J Gastroenterol2008https://conductscience.org/library/papers/18350600PubMed
1719646808Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.Cancer Lett2010https://conductscience.org/library/papers/19646808PubMed
1823166326Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer.J Biol Chem2013https://conductscience.org/library/papers/23166326PubMed
191377676A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.J Biol Chem1992https://conductscience.org/library/papers/1377676PubMed
202330056A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.Nature1990https://conductscience.org/library/papers/2330056PubMed

See all 30 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
35799301Circular dorsal ruffles disturb the growth factor-induced PI3K-AKT pathway in hepatocellular carcinoma Hep3B cells.Cell Commun Signal2022https://conductscience.org/library/papers/35799301PubMed
35611205Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.World J Clin Cases2022https://conductscience.org/library/papers/35611205PubMed
32033443The IGF-II-Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives.Cancers (Basel)2020https://conductscience.org/library/papers/32033443PubMed
31270394Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma.Oncogene2019https://conductscience.org/library/papers/31270394PubMed

Download CSV of cited by

Genes27

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
IGF23481PubTator's text mininghttps://conductscience.org/library/genes/3481NCBI Gene
IGF2R3482PubTator's text mininghttps://conductscience.org/library/genes/3482NCBI Gene
IGFBP13484PubTator's text mininghttps://conductscience.org/library/genes/3484NCBI Gene
IGFBP23485PubTator's text mininghttps://conductscience.org/library/genes/3485NCBI Gene
IGFBP33486PubTator's text mininghttps://conductscience.org/library/genes/3486NCBI Gene
IGFBP43487PubTator's text mininghttps://conductscience.org/library/genes/3487NCBI Gene
IGFBP53488PubTator's text mininghttps://conductscience.org/library/genes/3488NCBI Gene
IGFBP63489PubTator's text mininghttps://conductscience.org/library/genes/3489NCBI Gene
IL113589PubTator's text mininghttps://conductscience.org/library/genes/3589NCBI Gene
IL1R13554PubTator's text mininghttps://conductscience.org/library/genes/3554NCBI Gene
IL2159067PubTator's text mininghttps://conductscience.org/library/genes/59067NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
IL6ST3572PubTator's text mininghttps://conductscience.org/library/genes/3572NCBI Gene
INSR3643PubTator's text mininghttps://conductscience.org/library/genes/3643NCBI Gene

See all 27 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29933129

GET https://conductscience.org/api/papers/v1/29933129/references?page=2